AD MEDIC LIMITED

Company Registration Number:
14202152 (England and Wales)

Unaudited micro entity accounts for the year ended 30 June 2025

Period of accounts

Start date: 01 July 2024

End date: 30 June 2025

AD MEDIC LIMITED

Contents of the Financial Statements

for the Period Ended 30 June 2025

Company Information - 3
Balance sheet - 4
Footnotes to the Balance Sheet - 6

AD MEDIC LIMITED

Company Information

for the Period Ended 30 June 2025




Registered office: 21
Anstey Fields
Birmingham
England
B23 5RL
Company Registration Number: 14202152 (England and Wales)

AD MEDIC LIMITED

Balance sheet

As at 30 June 2025


2025
£

2024
£
Fixed Assets: 59,080
Current assets: 36,831 51,639
Creditors: amounts falling due within one year: ( 5,536 ) ( 27,013 )
Net current assets (liabilities): 31,295 24,626
Total assets less current liabilities: 90,375 24,626
Creditors: amounts falling due after more than one year: ( 54,070 )
Total net assets (liabilities): 36,305 24,626
Capital and reserves: 36,305 24,626

AD MEDIC LIMITED

Balance sheet continued

For the year ending 30 June 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 24 July 2025
And Signed On Behalf Of The Board By:

Name: Dr Mazhar Shakir
Status: Director

The notes form part of these financial statements

AD MEDIC LIMITED

Footnotes to the Financial Statements

for the Period Ended 30 June 2025

  • 1. Employee Information

    Average number of employees: 1

AD MEDIC LIMITED

Footnotes to the Financial Statements

for the Period Ended 30 June 2025

  • 2. Off balance sheet disclosure

    No